Clinical data | |
---|---|
Pronunciation | /ˌpɛntɒkˈsɪfɪliːn, -ɪn/ |
Trade names | Trental, many other names worldwide[1] |
Other names | oxpentifylline (former AAN)[2] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a685027 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 10–30%[3] |
Metabolism | Hepatic and via erythrocytes |
Elimination half-life | 0.4–0.8 hours (1–1.6 hours for active metabolite)[3] |
Excretion | Urine (95%), faeces (<4%)[3] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.026.704 |
Chemical and physical data | |
Formula | C13H18N4O3 |
Molar mass | 278.312 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Pentoxifylline, also known as oxpentifylline, is a xanthine derivative used as a drug to treat muscle pain in people with peripheral artery disease.[4] It is generic and sold under many brand names worldwide.[1]